Aptevo Therapeutics Inc. Restricted Cash and Cash Equivalents, Noncurrent
Aptevo Therapeutics Inc. (APVO) had Restricted Cash and Cash Equivalents, Noncurrent of $12.45 million as of 2018-06-30, per its 10-Q filed 2018-08-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Restricted Cash and Cash Equivalent, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2018-08-09
- 2018-06-30: Restricted Cash and Cash Equivalents, Noncurrent $12.45M.
- 2018-03-31: Restricted Cash and Cash Equivalents, Noncurrent $11.24M.
- 2017-12-31: Restricted Cash and Cash Equivalents, Noncurrent $10.00M.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2018-06-30 | $12.45M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $11.24M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $10.00M 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |